866-997-4948(US-Canada Toll Free)

United States Glycosylated Peptide Market Report 2017

Published By :

QYResearch

Published Date : Jun 2017

Category :

Pharmaceutical

No. of Pages : 97 Pages

In this report, the United States Glycosylated Peptide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Glycosylated Peptide in these regions, from 2012 to 2022 (forecast).

United States Glycosylated Peptide market competition by top manufacturers/players, with Glycosylated Peptide sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer Inc
Sandoz International GmbH
Teva Pharmaceuticals Industries Ltd
Roche Ltd
Celltrion Inc
Dr.Reddy's Laboratories Ltd
Biocon Ltd
...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
mAb
EPO
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Glycosylated Peptide for each application, including
Oncology
Blood Disorder
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Glycosylated Peptide Market Report 2017
1 Glycosylated Peptide Overview
1.1 Product Overview and Scope of Glycosylated Peptide
1.2 Classification of Glycosylated Peptide by Product Category
1.2.1 United States Glycosylated Peptide Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Glycosylated Peptide Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 mAb
1.2.4 EPO
1.2.5 Others
1.3 United States Glycosylated Peptide Market by Application/End Users
1.3.1 United States Glycosylated Peptide Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Oncology
1.3.3 Blood Disorder
1.3.4 Others
1.4 United States Glycosylated Peptide Market by Region
1.4.1 United States Glycosylated Peptide Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Glycosylated Peptide Status and Prospect (2012-2022)
1.4.3 Southwest Glycosylated Peptide Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Glycosylated Peptide Status and Prospect (2012-2022)
1.4.5 New England Glycosylated Peptide Status and Prospect (2012-2022)
1.4.6 The South Glycosylated Peptide Status and Prospect (2012-2022)
1.4.7 The Midwest Glycosylated Peptide Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Glycosylated Peptide (2012-2022)
1.5.1 United States Glycosylated Peptide Sales and Growth Rate (2012-2022)
1.5.2 United States Glycosylated Peptide Revenue and Growth Rate (2012-2022)

2 United States Glycosylated Peptide Market Competition by Players/Suppliers
2.1 United States Glycosylated Peptide Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Glycosylated Peptide Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Glycosylated Peptide Average Price by Players/Suppliers (2012-2017)
2.4 United States Glycosylated Peptide Market Competitive Situation and Trends
2.4.1 United States Glycosylated Peptide Market Concentration Rate
2.4.2 United States Glycosylated Peptide Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Glycosylated Peptide Manufacturing Base Distribution, Sales Area, Product Type

3 United States Glycosylated Peptide Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Glycosylated Peptide Sales and Market Share by Region (2012-2017)
3.2 United States Glycosylated Peptide Revenue and Market Share by Region (2012-2017)
3.3 United States Glycosylated Peptide Price by Region (2012-2017)

4 United States Glycosylated Peptide Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Glycosylated Peptide Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Glycosylated Peptide Revenue and Market Share by Type (2012-2017)
4.3 United States Glycosylated Peptide Price by Type (2012-2017)
4.4 United States Glycosylated Peptide Sales Growth Rate by Type (2012-2017)

5 United States Glycosylated Peptide Sales (Volume) by Application (2012-2017)
5.1 United States Glycosylated Peptide Sales and Market Share by Application (2012-2017)
5.2 United States Glycosylated Peptide Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Glycosylated Peptide Players/Suppliers Profiles and Sales Data
6.1 Pfizer Inc
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Glycosylated Peptide Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Inc Glycosylated Peptide Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Sandoz International GmbH
6.2.2 Glycosylated Peptide Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Sandoz International GmbH Glycosylated Peptide Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Teva Pharmaceuticals Industries Ltd
6.3.2 Glycosylated Peptide Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Teva Pharmaceuticals Industries Ltd Glycosylated Peptide Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Roche Ltd
6.4.2 Glycosylated Peptide Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Roche Ltd Glycosylated Peptide Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Celltrion Inc
6.5.2 Glycosylated Peptide Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Celltrion Inc Glycosylated Peptide Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Dr.Reddy's Laboratories Ltd
6.6.2 Glycosylated Peptide Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Dr.Reddy's Laboratories Ltd Glycosylated Peptide Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Biocon Ltd
6.7.2 Glycosylated Peptide Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Biocon Ltd Glycosylated Peptide Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
...

7 Glycosylated Peptide Manufacturing Cost Analysis
7.1 Glycosylated Peptide Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Glycosylated Peptide

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Glycosylated Peptide Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Glycosylated Peptide Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Glycosylated Peptide Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Glycosylated Peptide Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Glycosylated Peptide Sales Volume Forecast by Type (2017-2022)
11.3 United States Glycosylated Peptide Sales Volume Forecast by Application (2017-2022)
11.4 United States Glycosylated Peptide Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Glycosylated Peptide
Figure United States Glycosylated Peptide Market Size (K MT) by Type (2012-2022)
Figure United States Glycosylated Peptide Sales Volume Market Share by Type (Product Category) in 2016
Figure mAb Product Picture
Figure EPO Product Picture
Figure Others Product Picture
Figure United States Glycosylated Peptide Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Glycosylated Peptide by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Blood Disorder Examples
Table Key Downstream Customer in Blood Disorder
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Glycosylated Peptide Market Size (Million USD) by Region (2012-2022)
Figure The West Glycosylated Peptide Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Glycosylated Peptide Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Glycosylated Peptide Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Glycosylated Peptide Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Glycosylated Peptide Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Glycosylated Peptide Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Glycosylated Peptide Sales (K MT) and Growth Rate (2012-2022)
Figure United States Glycosylated Peptide Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Glycosylated Peptide Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Glycosylated Peptide Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Glycosylated Peptide Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Glycosylated Peptide Sales Share by Players/Suppliers
Figure 2017 United States Glycosylated Peptide Sales Share by Players/Suppliers
Figure United States Glycosylated Peptide Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Glycosylated Peptide Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Glycosylated Peptide Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Glycosylated Peptide Revenue Share by Players/Suppliers
Figure 2017 United States Glycosylated Peptide Revenue Share by Players/Suppliers
Table United States Market Glycosylated Peptide Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Glycosylated Peptide Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Glycosylated Peptide Market Share of Top 3 Players/Suppliers
Figure United States Glycosylated Peptide Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Glycosylated Peptide Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Glycosylated Peptide Product Category
Table United States Glycosylated Peptide Sales (K MT) by Region (2012-2017)
Table United States Glycosylated Peptide Sales Share by Region (2012-2017)
Figure United States Glycosylated Peptide Sales Share by Region (2012-2017)
Figure United States Glycosylated Peptide Sales Market Share by Region in 2016
Table United States Glycosylated Peptide Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Glycosylated Peptide Revenue Share by Region (2012-2017)
Figure United States Glycosylated Peptide Revenue Market Share by Region (2012-2017)
Figure United States Glycosylated Peptide Revenue Market Share by Region in 2016
Table United States Glycosylated Peptide Price (USD/MT) by Region (2012-2017)
Table United States Glycosylated Peptide Sales (K MT) by Type (2012-2017)
Table United States Glycosylated Peptide Sales Share by Type (2012-2017)
Figure United States Glycosylated Peptide Sales Share by Type (2012-2017)
Figure United States Glycosylated Peptide Sales Market Share by Type in 2016
Table United States Glycosylated Peptide Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Glycosylated Peptide Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Glycosylated Peptide by Type (2012-2017)
Figure Revenue Market Share of Glycosylated Peptide by Type in 2016
Table United States Glycosylated Peptide Price (USD/MT) by Types (2012-2017)
Figure United States Glycosylated Peptide Sales Growth Rate by Type (2012-2017)
Table United States Glycosylated Peptide Sales (K MT) by Application (2012-2017)
Table United States Glycosylated Peptide Sales Market Share by Application (2012-2017)
Figure United States Glycosylated Peptide Sales Market Share by Application (2012-2017)
Figure United States Glycosylated Peptide Sales Market Share by Application in 2016
Table United States Glycosylated Peptide Sales Growth Rate by Application (2012-2017)
Figure United States Glycosylated Peptide Sales Growth Rate by Application (2012-2017)
Table Pfizer Inc Basic Information List
Table Pfizer Inc Glycosylated Peptide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Inc Glycosylated Peptide Sales Growth Rate (2012-2017)
Figure Pfizer Inc Glycosylated Peptide Sales Market Share in United States (2012-2017)
Figure Pfizer Inc Glycosylated Peptide Revenue Market Share in United States (2012-2017)
Table Sandoz International GmbH Basic Information List
Table Sandoz International GmbH Glycosylated Peptide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sandoz International GmbH Glycosylated Peptide Sales Growth Rate (2012-2017)
Figure Sandoz International GmbH Glycosylated Peptide Sales Market Share in United States (2012-2017)
Figure Sandoz International GmbH Glycosylated Peptide Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceuticals Industries Ltd Basic Information List
Table Teva Pharmaceuticals Industries Ltd Glycosylated Peptide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Teva Pharmaceuticals Industries Ltd Glycosylated Peptide Sales Growth Rate (2012-2017)
Figure Teva Pharmaceuticals Industries Ltd Glycosylated Peptide Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceuticals Industries Ltd Glycosylated Peptide Revenue Market Share in United States (2012-2017)
Table Roche Ltd Basic Information List
Table Roche Ltd Glycosylated Peptide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Roche Ltd Glycosylated Peptide Sales Growth Rate (2012-2017)
Figure Roche Ltd Glycosylated Peptide Sales Market Share in United States (2012-2017)
Figure Roche Ltd Glycosylated Peptide Revenue Market Share in United States (2012-2017)
Table Celltrion Inc Basic Information List
Table Celltrion Inc Glycosylated Peptide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Celltrion Inc Glycosylated Peptide Sales Growth Rate (2012-2017)
Figure Celltrion Inc Glycosylated Peptide Sales Market Share in United States (2012-2017)
Figure Celltrion Inc Glycosylated Peptide Revenue Market Share in United States (2012-2017)
Table Dr.Reddy's Laboratories Ltd Basic Information List
Table Dr.Reddy's Laboratories Ltd Glycosylated Peptide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Dr.Reddy's Laboratories Ltd Glycosylated Peptide Sales Growth Rate (2012-2017)
Figure Dr.Reddy's Laboratories Ltd Glycosylated Peptide Sales Market Share in United States (2012-2017)
Figure Dr.Reddy's Laboratories Ltd Glycosylated Peptide Revenue Market Share in United States (2012-2017)
Table Biocon Ltd Basic Information List
Table Biocon Ltd Glycosylated Peptide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Biocon Ltd Glycosylated Peptide Sales Growth Rate (2012-2017)
Figure Biocon Ltd Glycosylated Peptide Sales Market Share in United States (2012-2017)
Figure Biocon Ltd Glycosylated Peptide Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Glycosylated Peptide
Figure Manufacturing Process Analysis of Glycosylated Peptide
Figure Glycosylated Peptide Industrial Chain Analysis
Table Raw Materials Sources of Glycosylated Peptide Major Players/Suppliers in 2016
Table Major Buyers of Glycosylated Peptide
Table Distributors/Traders List
Figure United States Glycosylated Peptide Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Glycosylated Peptide Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Glycosylated Peptide Price (USD/MT) Trend Forecast (2017-2022)
Table United States Glycosylated Peptide Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Glycosylated Peptide Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Glycosylated Peptide Sales Volume (K MT) Forecast by Type in 2022
Table United States Glycosylated Peptide Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Glycosylated Peptide Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Glycosylated Peptide Sales Volume (K MT) Forecast by Application in 2022
Table United States Glycosylated Peptide Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Glycosylated Peptide Sales Volume Share Forecast by Region (2017-2022)
Figure United States Glycosylated Peptide Sales Volume Share Forecast by Region (2017-2022)
Figure United States Glycosylated Peptide Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *